Copyright
©The Author(s) 2025.
World J Transplant. Mar 18, 2025; 15(1): 96025
Published online Mar 18, 2025. doi: 10.5500/wjt.v15.i1.96025
Published online Mar 18, 2025. doi: 10.5500/wjt.v15.i1.96025
Ref. | Year of publication | Biomarker name | Type of fluid | Method of quantification | No. of samples | Condition evaluated | Data availability |
Buscher et al[35] | 2023 | HGF, IGFB, P6, CD40, CX3CL1, SPARCL1 | Plasma | Mass cytometry, PEA | 39 | Allograft function and rejection status | Yes |
Başak Oktay et al[20] | 2022 | CXCL10 | Urine | LC-MS/MS, ELISA | 18 | Chronic allograft dysfunction | No |
Jeon et al[26] | 2022 | RBP4 | Urine | LC-MS/MS, ELISA | 49 | Evaluation of renal graft function | On request |
Carreras-Planella et al[24] | 2021 | Vitronectin | Urine | LC-MS/MS, ELISA | 59 | Assessment of fibrosis in kidney graft | No |
Navarrete et al[22] | 2020 | Proteinase 3 | Urine | Serine hydrolase ABPP with Nano-RP LC–MS/MS | 32 | Subclinical rejection | |
Braun et al[36] | 2020 | PCK2 | Urine | (Western blot, SDS-PAGE, IHC validation), nano-LC-MS/MS - both untargeted and targeted using PRM | 22 | Prediction of long-term graft outcome | Yes |
Thorne et al[33] | 2020 | S-troponin and S-myoglobin | Plasma | LC-MS/MS, ELISA | 225 | Subclinical effects of remote ischemic reconditioning | On request |
Bank et al[31] | 2019 | TIMP2 | Urine | sandwich ELISA | 83 | Prediction of the occurrence and duration of functionally defined delayed graft function | Yes |
Al-Nedawi et al[25] | 2019 | TFIID subunit 1, 3-hydroxy-3-methylglutaryl coenzyme A reductase, FN1 protein, Spectrin beta chain, Protein AMBP, Alpha-1-acid glycoprotein 2, Dynein heavy chain 3, axonemal, Insulin receptor substrate 1, Prothrombin, Alpha-1-acid glycoprotein 1, Melanotransferrin, Catalase, DIS3-like exonuclease 1, Kinetochore-associated protein 1, Keratin, type II cuticular Hb6, Neuroblast differentiation-associated protein AHNAK, Apolipoprotein E, Angiotensinogen, Vitamin D-binding protein, EGF-containing fibulin-like extracellular matrix protein 1, Keratin, type II cytoskeletal 3, DNA repair protein RAD50, Receptor-type tyrosine-protein phosphatase, Apolipoprotein A-II, Transthyretin, Hemoglobin subunit beta | Plasma | (SDS-PAGE), MS/MS | 30 | eGFR correlation and graft function evaluation | No |
Mockler et al[29] | 2018 | CXCL10 | Urine | LC-MS/MS (to measure creatinine), sandwich ELISA (to measure CXCL10 and CCL2) | 59 | Correlation with eGFR and long term renal graft outcome | No |
Williams et al[32] | 2017 | C4BPA, alpha, guanylin, immunoglob- ulin superfamily member 8, and serum amyloid P- component. | Urine | TUPA (scheduled LC-MRM this is a type of MS), sandwich ELISA | 52 | Diagnosis of Delayed graft function | Yes |
Hirt-Minkowski et al[27] | 2016 | CCL2, CXCL10 | Urine | ELISA | 185 | Prediction of long-term renal graft outcome | Yes |
Hirt-Minkowski et al[28] | 2015 | CXCL10 | Urine | sandwich ELISA | 154 | Long-term renal allograft outcome evaluation | Yes |
Ho et al[23] | 2016 | MMP7 | Urine | LC-MS/MS, ELISA | 17 | Subclinical graft injury and inflammation | Yes |
Sigdel et al[21] | 2013 | ACAN, CLEC14A, GLB1, LGALS9B, LMAN2, MRC2 SEL, CD27, DPEP1, and F2 | Urine | iTRAQ labeling, LC-MS/MS, ELISA | 142 | Evaluation of chronic allograft injury | Yes |
Welberry Smith et al[30] | 2013 | Aminoacylase-1 | Serum | LC-MS/MS, sandwich ELISA | 194 | Prediction of long-term outcome in patients with delayed graft function | Yes |
Schmidt et al[34] | 2013 | Chitinase-3-like protein 1 | Urine | MS | 78 | Evaluation of delayed graft injury and prediction of long-term renal graft outcome | Yes |
Name | UniProt code | Cellular location | Sample type | Status | Code gene |
Hepatocyte growth factor | P14210 | Membrane, extracellular space | Plasma | Elevated | HGF |
Insulin growth factor binding protein 6 | P24592 | Secreted | Plasma | Elevated | IGFBP6 |
CD40 | P25942 | Cell membrane and secreted | Plasma | Elevated | CD40 |
Fractalkine | P78423 | Cell membrane | Plasma | Elevated | CX3CL1 |
SPARC-like protein 1 | Q14515 | Secreted, extracellular space and extracellular matrix | Plasma | Elevated | SPARCL1 |
C-X-C motif chemokine 10 | P02778 | Secreted, plasma membrane | Urine | Elevated | CXCL10 |
Retinol-binding protein 4 | P02766 | Cell wall, organelle, Secreted | Urine | Elevated | RBP4 |
Phosphoenolpyruvate carboxykinase 2 | Q16822 | Mitochondrion, ribosome | Urine | Elevated | PCK2 |
S troponin | P19429 | Cytosol and sarcomere | Serum | Elevated | TNNI3 |
S myoglobin | P02144 | Cytoplams and sarcoplasm | Serum | Elevated | MB |
TIMP2 | P16035 | cytoplasmic vesicle, organelle, Secreted | Urine | Elevated | TIMP2 |
CCL2 | P13500 | Secreted | Urine | Elevated | CCL2 |
MMP7 | P09237 | Secreted, extracellular space, extracellular matrix | Urine | Elevated | MMP7 |
Aminoacylase-1 | Q03154 | Cytoplasm | Serum | Elevated | ACY1 |
Chitinase-3-like protein 1 | P36222 | Cytoplasm, endoplasmic reticulum, secreted | Urine | Elevated | CHI3 L1 |
Protein AMBP | P02760 | Extracellular region, secreted | Plasma | Elevated | AMBP |
Alpha-1-acid glycoprotein 2 | P19652 | Extracellular region, secreted | Plasma | Elevated | ORM2 |
Dynein heavy chain 3 | Q8TD57 | Cytoskeleton, cilium axoneme | Plasma | Elevated | DNAH3 |
Insulin receptor substrate 1 | P06213 | Cytosol, nucleus, plasma membrane, caveola | Plasma | Elevated | INSR |
Catalase | P04040 | Peroxisome | Plasma | Elevated | CAT |
DIS3-like exonuclease 1 | Q8TF46 | Cytoplasm | Plasma | Elevated | DIS3 L |
Kinetochore-associated protein 1 | P50748 | Cytoskeleton, spindle, nucleus, cytoplasm | Plasma | Elevated | KNTC1 |
Apolipoprotein E | P02649 | Extracellular region, secreted | Plasma | Elevated | APOE |
Angiotensinogen | P01019 | Extracellular region, secreted | Plasma | Elevated | AGT |
Vitamin D-binding protein | P02774 | Extracellular region, secreted | Plasma | Elevated | GC |
EGF-containing fibulin-like extracellular matrix protein 1 | Q580Q6 | Extracellular region, secreted | Plasma | Elevated | EFEMP1 |
C4b-binding protein alpha chain | P04003 | Secreted | Urine | Elevated | C4BPA |
Serum amyloid P-component | P02743 | Secreted | Urine | Elevated | APCS |
Aggrecan core protein | P16112 | Secreted, extracellular space, extracellular matrix | Urine | Elevated | ACAN |
C-type lectin domain family 14 member A | Q86T13 | Membrane | Urine | Elevated | CLEC14A |
Beta-galactosidase | P54803 | Cytoplasm, lysosome | Urine | Elevated | GLB1 |
Galectin-9B | Q3B8N2 | Cytosol, nucleus | Urine | Elevated | LGALS9B |
Vesicular integral-membrane protein VIP36 | Q12907 | Endoplasmic reticulum, golgi apparatus, membrane | Urine | Elevated | LMAN2 |
C-type mannose receptor 2 | Q9UBG0 | Membrane | Urine | Elevated | MRC2 |
Protein sel-1 homolog 1 | Q9UBV2 | Endoplasmic reticulum membrane | Urine | Elevated | SEL1 L |
CD27 antigen | P26842 | Membrane | Urine | Elevated | CD27 |
Dipeptidase 1 | Q9H4A9 | Cell projection, microvillus membrane, cell membrane | Urine | Elevated | DPEP1 |
Transcription factor E2F2 | Q14209 | Nucleus | Urine | Elevated | E2F2 |
Keratin, type II cytoskeletal 3 | P12035 | Intermediate filament, keratin filament cytosol, exosome | Plasma | Decreased immediately, elevated 1 month after | KRT3 |
DNA repair protein RAD50 | Q92878 | Nucleus | Plasma | Decreased immediately, elevated 1 month after | RAD50 |
Receptor-type tyrosine-protein phosphatase | P23469 | Integral component of membrane | Plasma | Decreased immediately po, elevated 1 month after | PTPRE |
Vitronectin | P04004 | Endoplasmic reticulum, golgi apparatus, organelles, secreted | Urine | Detected only in fibrotic grafts | VTN |
proteinase 3 | P24158 | Lysosome, cytosol, plasma membrane, cytoplasmic vesicle, organelle, secreted | Urine | Increased activity | PRTN3 |
Transcription initiation factor TFIID subunit 1 | P21675 | Nucleus | Plasma | Decreased | TAF1 |
3-hydroxy-3-methylglutaryl coenzyme A reductase | P04035 | Endoplasmic reticulum, ER membrane | Plasma | Decreased | HMGCR |
Fibronectin | P02751 | Extracellular region, secreted | Plasma | Decreased | FN1 |
Spectrin beta chain, non-erythrocytic 1 | Q01082 | Cytoskeleton | Plasma | Decreased | SPTBN1 |
Apolipoprotein A-II | V9GYM3 | Extracellular region, secreted | Plasma | Decreased | APOA2 |
Transthyretin | E9KL36 | Extracellular region, secreted | Plasma | Decreased | HEL111 |
Hemoglobin subunit beta | P68871 | Cytosol, extracellular or secreted: Blood microparticle, exosome | Plasma | Decreased | HBB |
Guanylin | Q02747 | Secreted | Urine | Decreased | GUCA2A |
Immunoglobulin superfamily member 8 | Q969P0 | Cell membrane | Urine | Decreased | IGSF8 |
Prothrombin | P00734 | Extracellular region, secreted | Plasma | Elevated in good prognosis recipients | F2 |
Alpha-1-acid glycoprotein 1 | P02763 | Secreted | Plasma | Elevated in good prognosis recipients | ORM1 |
Melanotransferrin Isoform 1 | P08582 | Plasma membrane, GPI-anchor | Plasma | Elevated in good prognosis recipients | MELTF |
Apolipoprotein A-I | P02647 | Extracellular region, secreted | Plasma | Elevated in good prognosis recipients | APOA1 |
Keratin, type II cuticular Hb6 | O43790 | Cytoskeleton, keratin filament, cytosol extracellular region or secreted, exosome | Plasma | Elevated in good prognosis recipients | KRT86 |
Neuroblast differentiation-associated protein AHNAK | Q09666 | Cytoskeleton, centrosome | Plasma | Elevated in good prognosis recipients | AHNAK |
- Citation: Avramidou E, Psatha K, St John K, Tsoulfas G, Aivaliotis M. Future of non-invasive graft evaluation: A systematic review of proteomics in kidney transplantation. World J Transplant 2025; 15(1): 96025
- URL: https://www.wjgnet.com/2220-3230/full/v15/i1/96025.htm
- DOI: https://dx.doi.org/10.5500/wjt.v15.i1.96025